FDA: early efforts to prepare new drug labels 'not as good as we'd hoped'

Share this content:
"Not as good as we'd hoped" is the reaction by the FDA to early efforts by manufacturers to prepare Rx drug labels in conformance with the agency's new "content and format" requirements, in effect since publication of a final rule on the subject last summer.
Share this content:
Scroll down to see the next article